Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Aug;9(4):411-6.
doi: 10.1111/j.1365-2036.1995.tb00399.x.

Comparison of Pantoprazole Versus Omeprazole in the Treatment of Acute Duodenal Ulceration--A Multicentre Study

Affiliations
Clinical Trial

Comparison of Pantoprazole Versus Omeprazole in the Treatment of Acute Duodenal Ulceration--A Multicentre Study

M Rehner et al. Aliment Pharmacol Ther. .

Abstract

Methods: In this randomized, double-blind, multicentre study, the proton pump inhibitors pantoprazole and omeprazole were compared in patients with active duodenal ulcers. Two hundred and seventy-six protocol-correct patients received either pantoprazole 40 mg (n = 185) or omeprazole 20 mg (n = 91), once daily for 2 or 4 weeks, depending on the progress of ulcer healing.

Results: Rates of complete ulcer healing after 2 weeks were 71% in patients given pantoprazole and 74% in patients given omeprazole. After 4 weeks the figures were 96% and 91%, respectively. These differences were not significant. There was no significant difference in ulcer pain prior to treatment, and 85% of the pantoprazole group and 86% on omeprazole were pain-free after 2 weeks (not significant). The time until complete pain relief with pantoprazole or omeprazole, based on data from diary cards, was not significantly different (P > 0.05, Uleman's U-test). Both treatments were equally well tolerated. Changes in routine laboratory parameters were minimal in both groups.

Conclusion: Pantoprazole was shown to be a highly-effective and well-tolerated treatment for acute duodenal ulcer. Pantoprazole 40 mg and omeprazole 20 mg were equally effective with respect to ulcer healing and pain relief, and have similar adverse event profiles.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

LinkOut - more resources

Feedback